Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan.
Bioorg Chem. 2017 Feb;70:210-221. doi: 10.1016/j.bioorg.2017.01.001. Epub 2017 Jan 4.
A series of benzoxazinones 1-28 were synthesized via reaction of anthranilic acid with various substituted benzoyl chlorides in the presence of triethylamine in chloroform. Compounds 1-18 showed a good inhibition of α-chymotrypsin with IC±SEM values between 6.5 and 341.1μM. Preliminary structure-activity relationships studies indicated that the presence of substituents on benzene ring reduces the inhibitory potential of benzoxazinone. Also the increased inhibitory potential due to fluoro group at phenyl substituent was observed followed by chloro and bromo substituents. Compounds with strong electron donating or withdrawing groups on phenyl substituent, showed a good inhibitory potential at ortho>meta>para position. Kinetics studies showed diverse types of inhibition, except uncompetitive-type inhibition. The Ki values ranged between 4.7 and 341.2μM. Interestingly, most of these compounds were non-cytotoxic to 3T3 cell line at 30μM, except compounds 6, 14 and 15. Competitive inhibitors of chymotrypsin are like to inhibit other α-chymotrypsin-like serine proteases due to structural and functional similarities between them. The inhibitors identified during the current study deserve to be further studied for their therapeutic potential against abnormalities mediated by chymotrypsin or other serine protease.
一系列苯并恶嗪酮 1-28 通过在三乙胺存在下,用各种取代的苯甲酰氯与邻氨基苯甲酸在氯仿中反应合成。化合物 1-18 对α-糜蛋白酶表现出良好的抑制作用,IC±SEM 值在 6.5 和 341.1μM 之间。初步的构效关系研究表明,苯环上取代基的存在降低了苯并恶嗪酮的抑制潜力。另外,由于苯环上的氟取代基的存在,观察到抑制潜力增加,其次是氯和溴取代基。具有强供电子或吸电子取代基的化合物,在邻位>间位>对位显示出良好的抑制潜力。动力学研究表明,除了非竞争性抑制外,还存在多种类型的抑制。Ki 值范围在 4.7 和 341.2μM 之间。有趣的是,除了化合物 6、14 和 15 外,这些化合物在 30μM 时对 3T3 细胞系均无细胞毒性。由于它们之间在结构和功能上的相似性,糜蛋白酶的竞争性抑制剂可能会抑制其他α-糜蛋白酶样丝氨酸蛋白酶。在当前研究中鉴定的抑制剂值得进一步研究其在治疗由糜蛋白酶或其他丝氨酸蛋白酶介导的异常方面的潜在用途。